REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/12/2025
Voltar para busca
Dado oficial do USPTO
CARDIO RENAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
30/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
10, 42, 44
Data de depósito
31/10/2019
Data de registro
29/12/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/12/2020
Última transação
30/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
34
Localização do titular
FR
Examinador
MCDOWELL,MATTHEW J
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the words "CARDIO" and "RENAL" in white. The words appear inside two drops, one drop in gray containing the word "cardio", the other in blue containing the word "renal". A white line separates the two drops. A stylized representation of three blue soundwaves appear to the right of the blue drop.
Titulares e representantes
Titulares
CARDIORENAL
Representantes
Pina M. Campagna Carter, DeLuca, & Farrell, LLP
Classificação técnica
Classes Nice
Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Medical devices for monitoring cardiovascular diseases and renal diseases; medical monitoring devices for cardiovascular diseases and renal diseases; medical monitoring devices for cardiovascular failure and renal failure; heart rate monitors; medical instruments for recording and transmission of heart and kidney activity; apparatus and instruments for collecting and analyzing blood; lancets for blood samples
Classe 42
Services for designdevelopmentupdates and maintenance of softwaresoftware applications and software platforms; services for designdevelopmentupdates and maintenance of computer software incorporating algorithms; design and writing of computer programs in the medical field; design and writing of computer programs for medical applications; design and development of computer software for use in the framework of medical technology; development of computerized information systems using artificial intelligence technology for medical use; design and development of medical technologies for heart failure disease; providing scientific research for medical purposes in the field of heart failure disease; design and development of medical equipment used for medical diagnostic and medical monitoring purposes; development and testing of computer software and computer algorithms for use in establishing clinical research methodologies; design of computer database software; computer database design and development; maintenance of computer software databases; software as a service SaaS services featuring software for use in developing medical diagnostic tools in the field of heart failure disease; Computer platform as a service PaaS featuring computer software platforms for use in developing medical diagnostic tools in the field of heart failure disease; providing clinical research services in the field of heart failure disease; providing medical research services in the field of heart failure disease; providing scientific advisory services in the field of heart failure disease; Providing laboratory research services in the field of heart failure disease; providing automated biological research and analysis
Classe 44
Trans-telephonic heart monitoring services; Providing medical information in the field of heart failure disease; Medical patient diagnostic testingmonitoring and evaluation services; medical assistance; medical consultations; emergency medical assistance; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; telemedicine services; Providing an internet-based database of patient medical information supported by artificial intelligence software where patients can inquire about medical diagnosis and treatment optionsobtain personalized medical decision assistance services and receive follow up monitoring to determine efficacy of treatment provided; Technical support servicestroubleshooting in the nature of diagnosing problems with medical equipment as it relates to patient health; Medical consulting services in the proper use and applicability of medical treatment devices; Medical screening information services featuring reminder alerts regarding medical examinations that individuals should undergo for both continuing assessment and preventive care purposes; Providing medical information with respect to proper use and applicability of medical treatment devices
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/04/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/04/2021
FIMP
FINAL DISPOSITION PROCESSED
01/04/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/03/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
29/12/2020
GPNX
NOTIFICATION PROCESSED BY IB
18/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/10/2020
PUBO
PUBLISHED FOR OPPOSITION
13/10/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/09/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2020
DOCK
ASSIGNED TO EXAMINER
04/06/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/05/2020
RFNT
REFUSAL PROCESSED BY IB
27/03/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/03/2020
RFRR
REFUSAL PROCESSED BY MPU
05/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/02/2020
CNRT
NON-FINAL ACTION WRITTEN
11/02/2020
DOCK
ASSIGNED TO EXAMINER
05/02/2020
MAFR
APPLICATION FILING RECEIPT MAILED
18/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/01/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CARDIO RENAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.